The Metabolic Syndrome, Oxidative Stress, and the Liver

[1]  C. Aguilar-Salinas,et al.  The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. , 2016, Metabolism: clinical and experimental.

[2]  Rachel M. Brown,et al.  Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study , 2016, The Lancet.

[3]  G. Bruno,et al.  Prevalence of metabolic syndrome in the clinical practice of general medicine in Italy. , 2015, Cardiovascular diagnosis and therapy.

[4]  B. Neuschwander‐Tetri,et al.  Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial , 2015, The Lancet.

[5]  M. Uribe,et al.  Common features of the metabolic syndrome and nonalcoholic fatty liver disease. , 2015, Reviews on recent clinical trials.

[6]  S. Manti,et al.  Oxidative Stress in Obesity: A Critical Component in Human Diseases , 2014, International journal of molecular sciences.

[7]  N. Chavez-Tapia,et al.  The prevalence of nonalcoholic fatty liver disease in the Americas. , 2014, Annals of hepatology.

[8]  D. Schuppan,et al.  Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches , 2013, Journal of gastroenterology and hepatology.

[9]  S. Kalra,et al.  Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). , 2013, The Journal of the Association of Physicians of India.

[10]  A. Hofman,et al.  Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. , 2012, Journal of hepatology.

[11]  N. Chavez-Tapia,et al.  Role of oxidative stress and molecular changes in liver fibrosis: a review. , 2012, Current medicinal chemistry.

[12]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[13]  J. E. L. Peña,et al.  Prevalencia de hígado graso no alcohólico en individuos con síndrome metabólico , 2012 .

[14]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[15]  G. Musso,et al.  Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. , 2011, Antioxidants & redox signaling.

[16]  W. Schnedl,et al.  High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[17]  N. Méndez-Sánchez,et al.  The liver is the key organ for the development of metabolic syndrome. , 2011, Annals of hepatology.

[18]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[19]  B. Neuschwander‐Tetri,et al.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.

[20]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[21]  Joshi,et al.  Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. , 2009, The Journal of the Association of Physicians of India.

[22]  G. Salles,et al.  Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[23]  D. Pessayre.  Role of mitochondria in non‐alcoholic fatty liver disease , 2007, Journal of gastroenterology and hepatology.

[24]  M. Uribe,et al.  Current concepts in the pathogenesis of nonalcoholic fatty liver disease , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[25]  J. Machan,et al.  Nonalcoholic Fatty Liver Disease in Severely Obese Subjects , 2007, The American Journal of Gastroenterology.

[26]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[27]  M. T. M. Yagüe,et al.  Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. , 2006 .

[28]  T. Funahashi,et al.  Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[29]  Bohan Wang,et al.  Acute and prolonged effects of TNF-α on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture , 2006, Pflügers Archiv.

[30]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[31]  J. Shaw,et al.  The metabolic syndrome: prevalence in worldwide populations. , 2004, Endocrinology and metabolism clinics of North America.

[32]  D. Pessayre,et al.  The ins and outs of mitochondrial dysfunction in NASH. , 2004, Diabetes & metabolism.

[33]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[34]  C. Day.  Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[35]  A. Ceriello,et al.  Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment , 2002, Circulation.

[36]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[37]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[38]  J. Crespo,et al.  Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .

[39]  E. A. Sims,et al.  Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.

[40]  M. Birnbaum.  Turning down insulin signaling. , 2001, The Journal of clinical investigation.

[41]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[42]  K. Kaita,et al.  Fatty Infiltration of Liver in Hyperlipidemic Patients , 2000, Digestive Diseases and Sciences.

[43]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[44]  C. Day,et al.  Non-alcoholic steatohepatitis: another disease of affluence , 1999, The Lancet.

[45]  S. Basu,et al.  Metabolism of 8‐iso‐prostaglandin F2α , 1998 .

[46]  J. Chen,et al.  Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. , 1998, Biochimica et biophysica acta.

[47]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[48]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[49]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[50]  A. Hruszkewycz.  Evidence for mitochondrial DNA damage by lipid peroxidation. , 1988, Biochemical and biophysical research communications.

[51]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[52]  C. Palmeira,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free radical biology & medicine.

[53]  N. Chavez-Tapia,et al.  Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. , 2005, Annals of hepatology.